KCNJ11 and pancreatic neoplasm: Pharmacology/pharmacovigilance investigation showed that the KATP channel blockers sulfonylureas and glinides with high affinity and selective for Kir6.2-Sur1 channels within the drug class had the highest P.R.R. values for pancreatic cancers in unselected and uncontrolled population.